Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.95B | 13.44B | 10.78B | 4.80B | 1.64B | Gross Profit |
2.65B | 3.88B | 3.04B | 791.10M | -66.90M | EBIT |
1.56B | 2.06B | 1.44B | -339.60M | -839.40M | EBITDA |
3.07B | 3.06B | 2.28B | 325.30M | -467.90M | Net Income Common Stockholders |
1.61B | 1.92B | 1.31B | -240.80M | -1.02B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.96B | 4.11B | 4.66B | 3.12B | 3.77B | Total Assets |
17.51B | 17.18B | 16.41B | 12.33B | 14.75B | Total Debt |
2.68B | 2.75B | 4.12B | 5.43B | 4.21B | Net Debt |
-1.18B | -1.13B | 516.90M | 2.78B | 1.64B | Total Liabilities |
10.47B | 9.56B | 10.76B | 7.68B | 9.78B | Stockholders Equity |
7.04B | 7.61B | 5.64B | 4.65B | 4.97B |
Cash Flow | Free Cash Flow | |||
1.86B | 766.00M | 1.98B | -2.74B | 910.50M | Operating Cash Flow |
3.42B | 3.16B | 3.89B | -2.45B | 2.11B | Investing Cash Flow |
-1.43B | -1.56B | -1.90B | 937.10M | -918.10M | Financing Cash Flow |
-2.00B | -1.33B | -1.05B | 1.62B | -297.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $24.06B | 6.77 | 33.57% | ― | 5.31% | 35.95% | |
78 Outperform | $30.90B | 8.39 | 27.52% | 1.26% | 4.91% | -27.21% | |
73 Outperform | $28.41B | 17.52 | 22.41% | 1.68% | 3.12% | -13.82% | |
73 Outperform | $11.29B | 24.28 | 36.66% | 3.86% | -2.56% | -14.94% | |
68 Neutral | $17.76B | 37.00 | 5.63% | 2.31% | 3.26% | 27.77% | |
66 Neutral | $4.46B | 12.11 | 5.38% | 5.02% | 4.17% | -11.82% | |
61 Neutral | $6.96B | 12.21 | -21.27% | ― | 1.92% | 36.07% |